These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25944720)

  • 1. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
    Mackin KE; Elliott B; Kotsanas D; Howden BP; Carter GP; Korman TM; Riley TV; Rood JI; Jenkin GA; Lyras D
    Anaerobe; 2015 Aug; 34():80-3. PubMed ID: 25944720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
    Zheng L; Citron DM; Genheimer CW; Sigmon SF; Carman RJ; Lyerly DM; Goldstein EJ
    Anaerobe; 2007; 13(3-4):114-20. PubMed ID: 17531516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and antimicrobial susceptibility of tcdA-negative Clostridium difficile isolates from Guangzhou, China.
    Lidan C; Linhai L; Yang L; Zhaohui S; Xiaoyan H; Yuling S
    Diagn Microbiol Infect Dis; 2016 Apr; 84(4):361-5. PubMed ID: 26867962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
    Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole.
    Adler A; Miller-Roll T; Bradenstein R; Block C; Mendelson B; Parizade M; Paitan Y; Schwartz D; Peled N; Carmeli Y; Schwaber MJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):21-4. PubMed ID: 26116225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
    Chen YB; Gu SL; Shen P; Lv T; Fang YH; Tang LL; Li LJ
    J Med Microbiol; 2018 Jan; 67(1):52-59. PubMed ID: 29160203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.
    Secco DA; Balassiano IT; Boente RF; Miranda KR; Brazier J; Hall V; dos Santos-Filho J; Lobo LA; Nouér SA; Domingues RM
    Anaerobe; 2014 Aug; 28():85-9. PubMed ID: 24907488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin.
    Knight DR; Riley TV
    J Antimicrob Chemother; 2016 Aug; 71(8):2213-7. PubMed ID: 27130808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators.
    Freeman J; Vernon J; Vickers R; Wilcox MH
    Antimicrob Agents Chemother; 2016 Jan; 60(1):689-92. PubMed ID: 26552981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
    J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
    Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
    Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
    Piepenbrock E; Stelzer Y; Berger F; Jazmati N
    Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of MCB3681 against Clostridium difficile strains.
    Rashid MU; Dalhoff A; Weintraub A; Nord CE
    Anaerobe; 2014 Aug; 28():216-9. PubMed ID: 25016084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.